Wolverine Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,700
Closed -$259K 1821
2025
Q4
$259K Hold
2,700
﹤0.01% 1070
2025
Q3
$257K Sell
2,700
-26,800
-91% -$2.46M ﹤0.01% 978
2025
Q2
$2.57M Sell
29,500
-18,900
-39% -$1.6M 0.02% 471
2025
Q1
$4.35M Buy
48,400
+4,600
+11% +$412K 0.05% 329
2024
Q4
$3.5M Buy
43,800
+10,600
+32% +$918K 0.04% 386
2024
Q3
$2.99M Buy
33,200
+7,100
+27% +$597K 0.03% 411
2024
Q2
$2.05M Buy
26,100
+25,700
+6,425% +$2.11M 0.02% 499
2024
Q1
$34.9K Buy
+400
New +$34.1K ﹤0.01% 1152
2018
Q2
Sell
-25,000
Closed -$2M 1529
2018
Q1
$2M Buy
+25,000
New +$2.06M 0.03% 532
2015
Q1
Sell
-76
Closed -$23K 2052
2014
Q4
$23K Sell
76
-174
-70% -$12.1K ﹤0.01% 1591
2014
Q3
$97K Sell
250
-14
-5% -$890 ﹤0.01% 1315
2014
Q2
$149K Sell
264
-257
-49% -$15.6K ﹤0.01% 1022
2014
Q1
$131K Buy
521
+509
+4,242% +$29.6K ﹤0.01% 1026
2013
Q4
$7K Sell
12
-31
-72% -$1.76K ﹤0.01% 2315
2013
Q3
$31K Sell
43
-140
-77% -$7.53K ﹤0.01% 1887
2013
Q2
$71K Buy
+183
New +$9.05K ﹤0.01% 1551

Other funds holding MDT

Wolverine Asset Management's MDT Position: Q3 2025 in Review

Wolverine Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 5,010 shares — an estimated $461K sold.

Wolverine Asset Management first reported a position in MDT in Q2 2013 and held it in 18 quarters. The position peaked at $2.83M in Q4 2024. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Wolverine Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 5,010 Medtronic shares in Q3 2025, an estimated $461K.
  • Wolverine Asset Management first reported a position in Medtronic in Q2 2013 and held it in 18 quarters.
  • Wolverine Asset Management's Medtronic position peaked at $2.83M in Q4 2024.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.